Matrine derivate MASM suppresses LPS-induced phenotypic and functional maturation of murine bone marrow-derived dendritic cells.
Matrine derivate MASM suppresses LPS-induced phenotypic and functional maturation of murine bone marrow-derived dendritic cells.
复制标题
DOI:
10.1016/j.intimp.2016.04.022
复制
发表时间:
2016-07
影响因子:
5.6
通讯作者:
Jing Xu;Yang Qi;Wei-Heng Xu;Ying Liu;Lie Qiu;Ke-Qi Wang;Honggang Hu;Zhi-gao He;Jun-Ping Zhang-Jun-Ping
中科院分区:
文献类型:
--
作者:
Jing Xu;Yang Qi;Wei-Heng Xu;Ying Liu;Lie Qiu;Ke-Qi Wang;Honggang Hu;Zhi-gao He;Jun-Ping Zhang-Jun-Ping
Dendritic cell (DC) maturation process is a crucial step for the development of T cell immune responses and immune tolerance. In this study, we evaluated MASM, a novel derivative of the natural compound matrine that possesses a significant anti-inflammatory and immune-regulating property, for its efficacy to inhibit lipopolysaccharides (LPS)-induced maturation of murine bone marrow-derived dendritic cells. Here we show that MASM profoundly suppresses LPS-induced phenotypic and functional DC maturation. MASM inhibited LPS-induced expression of costimulatory molecules CD80 and CD86 in a concentration-dependent manner. MASM also attenuated LPS-induced IL-12p70, TNF-α, IL-6 and NO release of DCs. The MASM-treated DCs were highly efficient at antigen capture via mannose receptor-mediated endocytosis but showed weak stimulatory capacity for allogeneic T cell proliferation. Furthermore, MASM inhibited LPS-induced PI3K/Akt, MAPK and NF-κB pathways. These novel findings provide new insight into the immunopharmacological role of MASM in impacting on the DCs.